Corticotropin-releasing hormone (CRH) is a hypothalamic peptide hormone produced primarily by parvocellular neurons of the paraventricular nucleus. It is released into the hypophyseal portal circulation and stimulates anterior pituitary corticotrophs to secrete adrenocorticotropic hormone, forming the hypothalamic component of the hypothalamic-pituitary-adrenal axis.
Corticotropin-releasing hormone (CRH), also called corticotropin-releasing factor (CRF), is a peptide hormone produced primarily by specialized neurons of the hypothalamus. Its principal endocrine function is to stimulate secretion of adrenocorticotropic hormone (ACTH) from corticotroph cells of the anterior pituitary.
CRH forms the hypothalamic component of the hypothalamic-pituitary-adrenal (HPA) axis. Through this pathway, signals originating in the central nervous system regulate adrenal cortical secretion of cortisol. CRH therefore occupies an important anatomical and functional position linking neural responses to stress, circadian signals, pituitary activity, and adrenal endocrine function.
The major endocrine CRH-producing neurons are located in the paraventricular nucleus (PVN) of the hypothalamus. Their axons project toward the median eminence, where CRH is released into the primary capillary plexus of the hypothalamo-hypophyseal portal system. Portal blood transports CRH directly to the anterior pituitary.
CRH is a peptide hormone. Human CRH consists of 41 amino acids and is synthesized as part of a larger precursor molecule before being processed into the biologically active peptide.
Unlike steroid hormones, CRH is water soluble and acts through cell-surface receptors rather than diffusing through the plasma membrane to bind nuclear receptors.
The principal hypothalamic source of CRH involved in regulation of the anterior pituitary is the paraventricular nucleus of the hypothalamus.
Within the PVN, CRH is particularly associated with parvocellular neurosecretory neurons. These neurons differ functionally from the magnocellular neurons involved primarily in oxytocin and vasopressin secretion from the posterior pituitary.
The paraventricular nucleus (PVN) is a hypothalamic nucleus located adjacent to the third ventricle. It contains several neuronal populations with distinct projections and physiological functions.
Parvocellular neurosecretory neurons involved in the HPA axis project toward the median eminence and release CRH into the portal circulation.
Parvocellular neurons are relatively small neurosecretory neurons that synthesize hypothalamic releasing hormones and project to the median eminence.
CRH-producing parvocellular neurons provide the neural origin of the endocrine signal that ultimately controls pituitary ACTH secretion.
CRH is synthesized within hypothalamic neurons as a peptide precursor. Following transcription and translation, the precursor undergoes intracellular processing to generate mature CRH.
The peptide is packaged into secretory vesicles and transported along neuronal processes toward neurosecretory terminals.
Axons of hypophysiotropic CRH neurons descend toward the median eminence at the base of the hypothalamus.
CRH-containing secretory vesicles accumulate in nerve terminals positioned near the specialized capillary network of the hypothalamo-hypophyseal portal system.
The median eminence is a neurovascular region at the base of the hypothalamus that serves as a major interface between hypothalamic neurosecretory neurons and the pituitary portal circulation.
Hypothalamic releasing and inhibiting hormones enter blood vessels in this region rather than traveling directly through axons into the anterior pituitary.
Activation of CRH-producing neurons results in release of CRH from neurosecretory terminals in the median eminence.
The hormone enters the fenestrated capillaries of the primary capillary plexus and is carried toward the anterior pituitary through portal vessels.
The hypothalamo-hypophyseal portal system is a specialized vascular connection between the hypothalamus and anterior pituitary. It allows small quantities of hypothalamic regulatory hormones to reach pituitary cells at relatively high concentrations without first being diluted throughout the systemic circulation.
This vascular arrangement is fundamental to endocrine communication between the hypothalamus and adenohypophysis.
| Step | Structure or Event |
|---|---|
| 1 | CRH is synthesized by hypothalamic parvocellular neurons |
| 2 | Neurons project toward the median eminence |
| 3 | CRH is released into the primary capillary plexus |
| 4 | Portal veins transport CRH toward the anterior pituitary |
| 5 | CRH enters the secondary capillary plexus |
| 6 | CRH binds receptors on anterior pituitary corticotrophs |
| 7 | Corticotrophs increase ACTH synthesis and secretion |
The principal endocrine target of hypothalamic CRH is the corticotroph population of the anterior pituitary.
Corticotrophs synthesize the precursor protein proopiomelanocortin and process it to generate ACTH and related peptides.
Corticotrophs are endocrine cells located within the adenohypophysis. They represent the pituitary component of the HPA axis.
CRH stimulation increases both synthesis and secretion of ACTH, allowing hypothalamic activity to control adrenal cortical function indirectly.
Proopiomelanocortin (POMC) is a precursor polypeptide synthesized by corticotroph cells. Proteolytic processing of POMC generates ACTH and other peptide products.
CRH promotes POMC gene expression as well as ACTH secretion.
Adrenocorticotropic hormone is released from the anterior pituitary into the systemic circulation. It travels to the adrenal glands and acts primarily on cells of the adrenal cortex.
ACTH is particularly important for regulation of cortisol production by the zona fasciculata.
CRH does not normally serve as the direct circulating regulator of adrenal cortical cells. Instead, its major endocrine effect on the adrenal cortex is mediated through pituitary ACTH.
This creates a hierarchical pathway in which the hypothalamus regulates the pituitary, and the pituitary regulates the adrenal cortex.
The HPA axis consists functionally of the hypothalamus, anterior pituitary, and adrenal cortex. CRH, ACTH, and cortisol are major hormonal components of this axis.
The system regulates the glucocorticoid response to physiological demands and contributes to metabolic, cardiovascular, immune, behavioral, and stress-related adaptation.
| Level | Hormone | Primary Target |
|---|---|---|
| Hypothalamus | CRH | Anterior pituitary corticotrophs |
| Anterior pituitary | ACTH | Adrenal cortex |
| Adrenal cortex | Cortisol | Multiple tissues and feedback sites |
CRH acts through membrane receptors belonging to the G protein-coupled receptor family. Two major receptor types are recognized: CRH receptor type 1 and CRH receptor type 2.
The endocrine stimulation of pituitary corticotrophs is mediated predominantly through CRH receptor type 1 (CRHR1).
CRHR1 is expressed prominently on anterior pituitary corticotrophs and mediates the classical ACTH-releasing effect of hypothalamic CRH.
Activation of this receptor stimulates intracellular signaling pathways that increase ACTH secretion and POMC expression.
CRHR2 is expressed in selected central and peripheral tissues and participates in signaling involving CRH-family peptides.
Its distribution and physiological functions differ from the dominant CRHR1-mediated regulation of pituitary ACTH secretion.
Binding of CRH to CRHR1 activates G protein-dependent signaling in corticotrophs. An important pathway involves stimulation of adenylyl cyclase and increased intracellular cyclic AMP (cAMP).
Downstream protein kinase signaling promotes ACTH secretion and transcriptional regulation of POMC.
| Step | Event |
|---|---|
| 1 | CRH binds CRHR1 on a corticotroph |
| 2 | G protein signaling is activated |
| 3 | Adenylyl cyclase activity increases |
| 4 | Intracellular cAMP rises |
| 5 | Protein kinase-dependent signaling is activated |
| 6 | ACTH secretion and POMC transcription increase |
Arginine vasopressin (AVP) can act together with CRH to stimulate ACTH secretion. Some parvocellular hypothalamic neurons involved in stress responses produce both CRH and vasopressin.
AVP can potentiate corticotroph responses to CRH, particularly during sustained activation of the HPA axis.
| Feature | CRH | Vasopressin |
|---|---|---|
| Major HPA role | Principal hypothalamic stimulator of ACTH | Potentiates ACTH secretion |
| Pituitary target | Corticotroph | Corticotroph |
| Important receptor | CRHR1 | V1b receptor |
| Major signaling pathway | Predominantly cAMP-related signaling | Predominantly phospholipase C-related signaling |
Cortisol is the principal glucocorticoid produced by the human adrenal cortex. ACTH stimulates cortisol synthesis and secretion, particularly from the zona fasciculata.
Cortisol subsequently acts on numerous tissues and provides negative feedback to the hypothalamus and pituitary.
Increasing cortisol concentrations suppress further activity of the HPA axis. This negative feedback limits excessive or prolonged glucocorticoid secretion.
Feedback occurs at multiple levels, including the hypothalamus and anterior pituitary.
Cortisol suppresses components of hypothalamic CRH activity. This reduces the stimulatory signal reaching anterior pituitary corticotrophs.
The hypothalamus therefore functions both as the origin of the endocrine cascade and as an important site of glucocorticoid feedback.
Cortisol also acts directly on corticotroph cells to reduce ACTH synthesis and secretion.
This provides an additional feedback mechanism for controlling adrenal glucocorticoid output.
| Signal | Effect |
|---|---|
| CRH | Stimulates ACTH secretion |
| ACTH | Stimulates adrenal cortisol production |
| Cortisol | Suppresses hypothalamic and pituitary components of the HPA axis |
CRH is a major neuroendocrine mediator of the stress response. Physical or psychological challenges can activate neural pathways that increase the activity of CRH-producing hypothalamic neurons.
The resulting increase in ACTH and cortisol helps coordinate physiological adaptations to changing demands.
HPA-axis activity can be influenced by numerous physiological challenges, including illness, injury, hypoglycemia, inflammation, major changes in the internal environment, and psychological stress.
The neural circuits processing these signals converge directly or indirectly on hypothalamic systems controlling CRH neurons.
During acute stress, activation of CRH neurons can rapidly increase ACTH secretion. Increased ACTH subsequently raises adrenal cortisol production.
Cortisol helps mobilize energy substrates and modifies cardiovascular, immune, and metabolic processes appropriate to the physiological challenge.
The stress response is not limited to the HPA axis. Hypothalamic and brainstem networks coordinate endocrine responses with autonomic activity.
CRH-related neural circuits therefore operate within a broader system that includes sympathetic nervous system activation and behavioral responses.
HPA-axis activity follows a strong circadian rhythm. Hypothalamic signals contribute to daily variation in CRH, ACTH, and cortisol secretion.
In individuals with a conventional sleep-wake schedule, cortisol concentrations generally rise during the latter part of sleep and are high around the time of awakening, then decline across much of the day.
The suprachiasmatic nucleus (SCN) of the hypothalamus is the principal central circadian pacemaker. It receives photic information indirectly from the retina and coordinates daily physiological rhythms.
Neural connections between circadian systems and the PVN contribute to rhythmic regulation of the HPA axis.
CRH and ACTH secretion are dynamic rather than continuous at a fixed rate. The HPA axis demonstrates pulsatile activity superimposed on its circadian rhythm.
These temporal patterns influence the pulsatile secretion of cortisol by the adrenal cortex.
HPA-axis activity interacts with sleep and wakefulness. Circadian regulation, sleep state, environmental stressors, and behavioral factors all influence the temporal pattern of cortisol secretion.
CRH participates in the hypothalamic signaling underlying these endocrine rhythms.
CRH is not restricted to the hypophysiotropic neurons controlling ACTH. CRH-containing neurons and CRH receptors are distributed in additional regions of the central nervous system.
These extrahypophysiotropic CRH systems participate in neural processes associated with stress-related behavior, autonomic regulation, and arousal.
CRH is particularly important because it functions at the interface between the nervous and endocrine systems. It is synthesized by neurons, released from nerve terminals, transported through specialized blood vessels, and acts on endocrine cells of the anterior pituitary.
It is therefore a classic example of a neurohormone.
A neurohormone is a signaling molecule synthesized by neurons and released into the circulation to act on distant target cells. Hypothalamic CRH meets this definition because its endocrine form is released into portal blood and transported to the anterior pituitary.
Hypothalamic CRH normally reaches corticotrophs through the pituitary portal system rather than relying on systemic circulation.
This arrangement permits efficient delivery of hypothalamic hormones to their pituitary targets while maintaining relatively low concentrations in the general circulation.
| Feature | CRH | ACTH |
|---|---|---|
| Primary source | Hypothalamic parvocellular neurons | Anterior pituitary corticotrophs |
| Hormone type | Peptide | Peptide |
| Primary target | Anterior pituitary corticotrophs | Adrenal cortex |
| Primary transport route | Hypophyseal portal circulation | Systemic circulation |
| Major effect | Stimulates ACTH | Stimulates adrenal glucocorticoid production |
| Feature | CRH | Cortisol |
|---|---|---|
| Hormone class | Peptide | Steroid |
| Primary source | Hypothalamus | Adrenal cortex |
| Position in HPA axis | Upstream hypothalamic signal | Peripheral effector hormone |
| Primary HPA action | Stimulates ACTH | Provides negative feedback |
| Principal receptor location | Cell-surface CRH receptors | Intracellular glucocorticoid receptors |
Inflammatory signals can activate the HPA axis through neural and humoral pathways. Increased glucocorticoid production subsequently modifies immune and inflammatory activity.
The CRH-ACTH-cortisol pathway therefore forms part of the interaction between the immune and endocrine systems.
Hypoglycemia is a potent physiological stimulus for activation of counter-regulatory systems, including the HPA axis.
Increased CRH and ACTH activity contributes to the cortisol response that helps maintain metabolic homeostasis during inadequate glucose availability.
Severe illness, surgery, trauma, and other major physiological stresses can alter HPA-axis activity. CRH-mediated stimulation of ACTH is one component of the endocrine response to these challenges.
The magnitude and temporal pattern of the response vary according to the type, severity, and duration of the stressor.
Repeated or prolonged activation of stress-responsive pathways can alter regulation of the HPA axis. Changes may occur at hypothalamic, pituitary, adrenal, and feedback levels.
The physiology of chronic stress is complex and cannot be explained by CRH concentration alone.
Pregnancy introduces an additional source of CRH outside the maternal hypothalamus. The placenta produces CRH, and maternal circulating CRH concentrations increase substantially as pregnancy progresses.
Placental CRH participates in the distinctive endocrine physiology of pregnancy.
Placental CRH differs physiologically from the classical hypothalamic portal CRH system because it is released into the maternal and fetal environments rather than solely into the pituitary portal circulation.
It participates in complex interactions involving fetal and maternal adrenal function and the timing of pregnancy-related endocrine events.
Regulation of placental CRH differs in important ways from hypothalamic CRH regulation. Glucocorticoids can enhance placental CRH expression, creating relationships that differ from the classical negative feedback exerted by cortisol on hypothalamic CRH.
This distinction is important when comparing pregnancy physiology with the conventional HPA axis.
A circulating CRH-binding protein (CRH-BP) binds CRH and influences its biological availability.
This binding system provides an additional level of regulation, particularly in physiological states where circulating CRH concentrations are increased.
Disorders associated with excessive cortisol production can alter normal HPA-axis feedback. Elevated glucocorticoid activity generally suppresses hypothalamic CRH and pituitary ACTH when the pathological source is independent of these upstream signals.
The specific hormonal pattern depends on the anatomical source of cortisol excess.
When excessive cortisol production is driven by pathological ACTH secretion, the relationship among CRH, ACTH, and cortisol differs from that seen with autonomous adrenal cortisol production.
Endocrine evaluation therefore uses the hierarchical organization of the HPA axis to help localize abnormalities.
Autonomous adrenal cortisol production increases negative feedback on both the hypothalamus and anterior pituitary.
This typically suppresses CRH drive and circulating ACTH.
When the adrenal cortex cannot produce adequate cortisol, loss of glucocorticoid negative feedback increases hypothalamic and pituitary drive.
CRH and ACTH activity consequently increase as the HPA axis attempts to stimulate the poorly functioning adrenal cortex.
Adrenal insufficiency can also result from inadequate hypothalamic or pituitary stimulation. Deficient CRH or ACTH signaling reduces stimulation of adrenal cortisol production.
This differs physiologically from primary adrenal failure, in which the adrenal gland itself is the principal site of dysfunction.
| Level | Example of Dysfunction | Physiological Consequence |
|---|---|---|
| Hypothalamus | Reduced CRH drive | Reduced pituitary ACTH stimulation |
| Anterior pituitary | Reduced ACTH secretion | Reduced adrenal cortisol stimulation |
| Adrenal cortex | Primary cortisol deficiency | Loss of feedback increases upstream HPA drive |
Glucocorticoids administered from outside the body can activate the same feedback mechanisms normally produced by endogenous cortisol.
Prolonged glucocorticoid exposure can therefore suppress hypothalamic CRH and pituitary ACTH activity.
After prolonged suppression, recovery of normal HPA-axis function may require time because hypothalamic, pituitary, and adrenal components have adapted to reduced endogenous stimulation.
The rate of recovery varies according to glucocorticoid exposure and individual physiological factors.
Exogenous CRH can be used in specialized endocrine evaluation to examine pituitary ACTH responsiveness.
The ACTH and cortisol responses to CRH must be interpreted together with the clinical context and other endocrine testing.
Because CRH directly stimulates corticotrophs, administration of CRH can provide information about the functional responsiveness of the pituitary component of the HPA axis.
It does not by itself provide a complete assessment of all causes of abnormal cortisol physiology.
CRH belongs to the group of hypothalamic hormones that regulate anterior pituitary secretion. Other members include thyrotropin-releasing hormone, gonadotropin-releasing hormone, and growth hormone-releasing hormone.
These hormones share the anatomical strategy of neurosecretion into the hypophyseal portal circulation.
| Hypothalamic Hormone | Major Pituitary Target | Major Pituitary Response |
|---|---|---|
| CRH | Corticotrophs | ACTH secretion |
| TRH | Thyrotrophs | TSH secretion |
| GnRH | Gonadotrophs | LH and FSH secretion |
| GHRH | Somatotrophs | Growth hormone secretion |
| Somatostatin | Somatotrophs and thyrotrophs | Inhibits GH and TSH secretion |
| Dopamine | Lactotrophs | Inhibits prolactin secretion |
CRH regulation demonstrates the distinctive anatomical relationship between the hypothalamus and anterior pituitary. CRH travels through blood vessels from hypothalamic nerve terminals to pituitary endocrine cells.
By contrast, hormones released from the posterior pituitary are synthesized in hypothalamic neurons and transported directly down axons to terminals within the neurohypophysis.
The CRH system depends on precise integration of neural and vascular anatomy. Hypothalamic neurons receive information from other brain regions, translate those signals into neurosecretory activity, and release CRH at the median eminence.
The portal vasculature then converts this neural output into a targeted endocrine signal delivered directly to the anterior pituitary.
| Feature | Key Point |
|---|---|
| Full name | Corticotropin-releasing hormone |
| Alternative name | Corticotropin-releasing factor |
| Hormone type | Peptide hormone |
| Length | 41 amino acids in humans |
| Major endocrine source | Parvocellular neurons of the hypothalamic paraventricular nucleus |
| Release site | Median eminence |
| Transport route | Hypothalamo-hypophyseal portal circulation |
| Primary target | Anterior pituitary corticotrophs |
| Major pituitary effect | Stimulates ACTH synthesis and secretion |
| Major receptor on corticotrophs | CRHR1 |
| Major downstream hormone | Cortisol through ACTH stimulation of the adrenal cortex |
| Major regulatory axis | Hypothalamic-pituitary-adrenal axis |
| Major feedback hormone | Cortisol |
CRH is a classic example of the anatomical integration of the hypothalamus, pituitary gland, and peripheral endocrine organs. Its endocrine pathway begins with parvocellular neurons in the paraventricular nucleus, extends through their axons to the median eminence, continues through the hypothalamo-hypophyseal portal circulation, and reaches corticotroph cells of the anterior pituitary.
This organization allows the central nervous system to regulate adrenal endocrine function without a direct neural connection between hypothalamic CRH neurons and the adrenal cortex. Instead, CRH stimulates ACTH secretion, and ACTH enters the systemic circulation to stimulate cortisol production by the adrenal cortex.
The pathway is tightly regulated through negative feedback. Cortisol generated at the end of the axis feeds back on hypothalamic and pituitary components, reducing further CRH and ACTH drive. This arrangement allows glucocorticoid production to increase when physiological demands require it while limiting excessive activation once sufficient cortisol is present.
CRH secretion is also integrated with circadian and stress-responsive neural networks. Signals associated with the sleep-wake cycle, metabolic disturbances, inflammation, illness, injury, and psychological stress can modify the activity of CRH neurons. The HPA axis therefore translates diverse neural and physiological information into coordinated endocrine responses.
Through its location in hypothalamic neurosecretory neurons, release at the median eminence, transport through the portal system, action on anterior pituitary corticotrophs, and regulation by cortisol feedback, CRH forms the initiating endocrine signal of the HPA axis and a major link between the nervous system and adrenal glucocorticoid physiology.